Recent investigations into this disorder have unraveled somatic mutations in genes encoding elements of the mitogen-activated protein kinase (MAPK) pathway, especially the BRAF gene, which is present in a significant number of cases of LCH. Here, BRAF is linked to Langerhans cell histiocytosis.